Journal of VitreoRetinal Diseases最新文献_第10页

Surgical Approaches to Serous Retinal Detachment With Retina-Lens Touch in Eyes With Nanophthalmos. 南眼球视网膜触及浆液性视网膜脱离的手术方法。

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-27 eCollection Date: 2024-03-01 DOI: 10.1177/24741264231220157

Ahmad M Mansour, Lorenzo López-Guajardo, Şengül Özdek, Ivajlo Popov, Maurizio Parodi Battaglia

{"title":"Surgical Approaches to Serous Retinal Detachment With Retina-Lens Touch in Eyes With Nanophthalmos.","authors":"Ahmad M Mansour, Lorenzo López-Guajardo, Şengül Özdek, Ivajlo Popov, Maurizio Parodi Battaglia","doi":"10.1177/24741264231220157","DOIUrl":"10.1177/24741264231220157","url":null,"abstract":"Purpose:To describe the visual outcomes and problems that resulted from surgical treatment of nanophthalmic complete retinal detachment (RD) with retina-lens contact. Methods: A multicenter retrospective case series with deep sclerectomy as a treatment was performed. Results: Five cases had extensive deep sclerectomies, 3 with intended drainage of subretinal fluid (SRF). The RD resolved 1 week postoperatively in 4 cases and within 1 month in 1 case. The visual acuity improved from light perception to a median of 20/100. Three cases had longstanding lens touch beyond 1 year and improved VA to 20/100, 20/150, and hand motions, respectively. Complications included focal lens dialysis in 2 cases (passive drainage of SRF) and lens or intraocular lens dislocation in 1 case each (active drainage of SRF). Ultrasound biomicroscopy and anterior optical coherence tomography showed a very narrow angle and short zonules. Conclusions: Deep sclerectomy results in good anatomic and functional improvements in advanced cases of nanophthalmos exudative detachment, which is often considered to be incurable.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"8 2","pages":"173-180"},"PeriodicalIF":0.6,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cytomegalovirus Retinitis Associated With Intravitreal Dexamethasone Implant Injection. 与玻璃体内注射地塞米松有关的巨细胞病毒视网膜炎

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-27 eCollection Date: 2024-03-01 DOI: 10.1177/24741264231221325

Marissa K Shoji, Jesse D Sengillo, Akaanksh Shetty, Joshua Uhr, Jayanth Sridhar

{"title":"Cytomegalovirus Retinitis Associated With Intravitreal Dexamethasone Implant Injection.","authors":"Marissa K Shoji, Jesse D Sengillo, Akaanksh Shetty, Joshua Uhr, Jayanth Sridhar","doi":"10.1177/24741264231221325","DOIUrl":"10.1177/24741264231221325","url":null,"abstract":"Purpose: To describe an immunocompetent patient with cytomegalovirus (CMV) retinitis after dexamethasone implant injection and review previously documented cases. Methods: A review of case reports and literature was performed. Results: A 75-year-old man presented with acute decreased vision in the left eye. He had a vitrectomy and membrane peeling for an epiretinal membrane with recurrent cystoid macular edema and was receiving intravitreal dexamethasone implant injections at an outside hospital. The visual acuity in the left eye was hand motions, and an examination found patchy retinal whitening with hemorrhages. Aqueous polymerase chain reaction was positive for CMV. The laboratory evaluation was negative for immunodeficiencies. He was treated successfully with intravitreal and oral antivirals; however, his vision remained poor at most recent follow-up. A literature review found 8 previous cases of CMV retinitis after dexamethasone implant injection, although most had underlying immune dysregulation. Conclusions: CMV retinitis after intravitreal dexamethasone implant injection is rare. Awareness of this complication is essential because of the risk for devastating blindness.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"8 2","pages":"215-219"},"PeriodicalIF":0.6,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes of Pars Plana Vitrectomy With Membrane Peel for Lamellar Macular Holes and Related Conditions Using a New Optical Coherence Tomography Consensus Definition 使用新的光学相干断层扫描共识定义进行带膜剥离的玻璃体旁切术治疗鳞状黄斑孔及相关病症的结果

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-24 DOI: 10.1177/24741264231218054

Taariq K. Mohammed, John T. Thompson

{"title":"Outcomes of Pars Plana Vitrectomy With Membrane Peel for Lamellar Macular Holes and Related Conditions Using a New Optical Coherence Tomography Consensus Definition","authors":"Taariq K. Mohammed, John T. Thompson","doi":"10.1177/24741264231218054","DOIUrl":"https://doi.org/10.1177/24741264231218054","url":null,"abstract":"Purpose: To characterize the change in visual acuity (VA) in eyes treated with vitrectomy using the 2020 international consensus-based optical coherence tomography (OCT) definition of lamellar macular hole (LMH), macular pseudohole (MPH), and epiretinal membrane with foveoschisis (ERMF). Methods: A retrospective chart review was performed from 2000 to 2022 of patients who had vitrectomy for symptomatic decreased VA from LMH, MPH, or ERMF performed by the same surgeon at a community hospital. Preoperative spectral domain (SD-OCT) was reviewed to classify patients using the consensus guidelines. Primary outcomes were the mean change in best-corrected VA at 3 months, 1 year, and the final postoperative examination. Results: Fifty-one patients were included, 30 with LMH, 14 with MPH, and 7 with ERMF. The VA was 20/63 at baseline, 20/62 ( P = .79) 3 months postoperatively, 20/40 ( P = .003) at 1 year, and 20/52 ( P = .10) at the final examination for LMH; 20/64, 20/50 ( P = .16), 20/40 ( P = .040), and 20/40 ( P = .02), respectively, for MPH; and 20/53, 20/50 ( P = .42), 20/30 ( P = .03), and 20/38 ( P = .04), respectively, for ERMF. Subgroup analysis showed that eyes with LMH without ellipsoid zone disruption on SD-OCT improved from 20/57 at baseline to 20/39 ( P = .01) at the final examination. Conclusions: There was no significant improvement in VA at the final postvitrectomy examination in eyes with LMH, while there was significant improvement in eyes with MPH and ERMF. This supports surgery in selected eyes with MPH and ERMF but possibly not in eyes with LMH, unless OCT shows no ellipsoid zone disruption.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"629 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139160584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Disparity in Medicare Reimbursement Between Female and Male Vitreoretinal Surgeons 女性和男性玻璃体视网膜外科医生在医疗保险报销方面的差异

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-23 DOI: 10.1177/24741264231215532

Aidan S. Gilson, Ron A. Adelman

{"title":"Disparity in Medicare Reimbursement Between Female and Male Vitreoretinal Surgeons","authors":"Aidan S. Gilson, Ron A. Adelman","doi":"10.1177/24741264231215532","DOIUrl":"https://doi.org/10.1177/24741264231215532","url":null,"abstract":"Purpose: To quantify the Medicare reimbursement disparity between female and male vitreoretinal surgeons. Methods: Reimbursement reports were obtained from the US Center for Medicare and Medicaid Services from 2013 through 2020, which detail all Medicare Part B services. A vitreoretinal surgeon was defined as any provider with at least 10 charges of a Healthcare Common Procedure Coding System code related to vitrectomy or retinal detachment repair. Providers were grouped by sex, and the average total reimbursement rate and additional secondary statistics to quantify the reimbursement disparity were identified. Results: On average, female vitreoretinal surgeons were reimbursed 65% that of their male counterparts in 2020, $1.66 million to $2.56 million. The percentage of the average male vitreoretinal specialist’s total reimbursement that the average female vitreoretinal specialist received decreased 8.8% from 2013 to 2020, from 73.8% to 65.0%. Conclusions: The reimbursement that the average female vitreoretinal surgeon receives from Medicare is only two thirds that of the average male vitreoretinal surgeon. In addition, there was no identifiable improvement in this disparity over the study period. Further efforts must be taken to establish concerted efforts to improve the reimbursement disparity and to identify the systematic inequities that led to its presence in the first place.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"123 2","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139161134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes of Scleral Buckling After Failed Pneumatic Retinopexy 气动视网膜成形术失败后的巩膜扣带术后效果

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-23 DOI: 10.1177/24741264231216795

Tuan Tran, Henry Chen, Bonnie He, D. Albiani, A. Kirker, A. Merkur, David Maberley, Zaid N Mammo

{"title":"Outcomes of Scleral Buckling After Failed Pneumatic Retinopexy","authors":"Tuan Tran, Henry Chen, Bonnie He, D. Albiani, A. Kirker, A. Merkur, David Maberley, Zaid N Mammo","doi":"10.1177/24741264231216795","DOIUrl":"https://doi.org/10.1177/24741264231216795","url":null,"abstract":"Purpose: To assess the visual and anatomic outcomes of eyes that had secondary scleral buckle (SB) surgery after unsuccessful pneumatic retinopexy (PR) for rhegmatogenous retinal detachment (RRD). Methods: A retrospective study, performed over a 12-year period, comprised patients who had secondary SB procedures after failed primary PR. Clinical parameters (eg, best-corrected visual acuity [BCVA], lens status, macula status, details of RRD and subretinal fluid) were assessed at presentation, before additional procedures, and at follow-up (6 months, 1 year, and last visit). Statistical comparisons were made using Brown-Forsythe and Welch analysis of variance tests, with significance levels set at P < .05. Results: Fifty-four eyes with adequate follow-up were included. Forty-four (81.5%) of 54 eyes had successful retinal reattachment with secondary SB alone. The remaining eyes had subsequent pars plana vitrectomy (PPV). Patients presenting with macula-on RRD who had successful secondary SB had no statistically significant change in BCVA from baseline (mean final logMAR 0.23 ± 0.25 [Snellen 20/34]; P = .999). There was a statistically significant improvement in BCVA in patients presenting with macula-off RRD who had successful secondary SB (mean final logMAR 0.32 ± 0.36 [20/42]; P < .001 and mean change in logMAR −1.06 ± 0.85). Ten patients presenting with macula-off RRD who had failed secondary SB had a significant improvement in the final BCVA (mean final logMAR 0.22 ± 0.28 [20/33]; P = .044), despite the need for an additional PPV to achieve reattachment. Conclusions: Secondary SB remains a good option for RRD repair after unsuccessful PR and may avoid the need for PPV.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"20 2","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139162886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee 玻璃体内注射 Pegcetacoplan 后的视网膜血管炎：ASRS 治疗研究与安全（ReST）委员会的报告

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-21 DOI: 10.1177/24741264231220224

A. Witkin, Glenn J. Jaffe, Sunil K. Srivastava, Janet L. Davis, Judy E. Kim

{"title":"Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee","authors":"A. Witkin, Glenn J. Jaffe, Sunil K. Srivastava, Janet L. Davis, Judy E. Kim","doi":"10.1177/24741264231220224","DOIUrl":"https://doi.org/10.1177/24741264231220224","url":null,"abstract":"Purpose: To analyze post-marketing cases of retinal vasculitis after intravitreal pegcetacoplan. Methods: The American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee as well as an expert panel performed a retrospective review of cases of retinal vasculitis reported to the ASRS. Clinical and imaging characteristics were reviewed for evidence of retinal vasculitis and analyzed. Results: Fourteen eyes of 13 patients were confirmed to have retinal vasculitis by review of imaging studies. All cases occurred after the first pegcetacoplan injection. Occlusive retinal vasculopathy was confirmed in 11 eyes (79%). Patients presented a median of 10.5 days (range, 8-23 days) after pegcetacoplan injection. All eyes had anterior chamber inflammation, and 12 eyes (86%) had vitritis. Vasculopathy involved retinal veins (100%) more than arteries (73%), and 12 eyes (86%) had retinal hemorrhages. The median visual acuity (VA) was 20/60 (range, 20/30-5/200) at baseline, 20/300 (range, 20/100-no light perception [NLP]) at vasculitis presentation, and 20/200 (range 20/70-NLP) at the last follow-up. Eight eyes (57%) had more than a 3-line decrease in VA, and 6 eyes (43%) had more than a 6-line decrease in VA from baseline to the final follow-up, including 2 eyes that were enucleated. Six eyes (43%) developed signs of anterior segment neovascularization. Conclusions: There is currently no known etiology for vasculitis in this series. Optimum treatment strategies remain unknown. Infectious etiologies should be considered, and corticosteroid treatments may hasten resolution of inflammatory findings. Continued treatment of affected patients with pegcetacoplan should be avoided.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"56 5","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138949718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bimanual Technique With Perfluoro-N-Octane for Human Amniotic Membrane Transplantation in Refractory Optic Disc Pit Maculopathy 使用全氟-N-正辛烷的双人羊膜移植技术治疗难治性视盘凹陷性黄斑病变

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-21 DOI: 10.1177/24741264231213433

M. Busquets

引用次数: 0

Implementation of a Teleophthalmology Screening Program for Diabetic Retinopathy in New York City 在纽约市实施糖尿病视网膜病变远程眼科筛查计划

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-18 DOI: 10.1177/24741264231208253

Pamela Capellan, Alexander B. Dillon, Geoff Rodriguez, Jason Chua, M. Mahrous, Kyle Kovacs, Sarah Van Tassel, Donald J. D’Amico, Szilárd Kiss, A. Orlin

{"title":"Implementation of a Teleophthalmology Screening Program for Diabetic Retinopathy in New York City","authors":"Pamela Capellan, Alexander B. Dillon, Geoff Rodriguez, Jason Chua, M. Mahrous, Kyle Kovacs, Sarah Van Tassel, Donald J. D’Amico, Szilárd Kiss, A. Orlin","doi":"10.1177/24741264231208253","DOIUrl":"https://doi.org/10.1177/24741264231208253","url":null,"abstract":"Purpose: To examine the implementation of a teleophthalmology program for diabetic retinopathy (DR) screening at a metropolitan hospital system and identify the challenges that the clinical teams encountered using the program. Methods: The study was conducted in 2 parts. The first was a pilot retrospective chart review of 300 consecutive patients screened for DR by the teleophthalmology screening program. The baseline variables, DR capture rate and staging, and continuity of care for those diagnosed with DR were analyzed. The second was a web-based survey identifying the barriers encountered by 36 physicians and clinical staff as they participated in the teleophthalmology screening program. Results: Part 1: Of the patients evaluated, 57 (19.0%) were diagnosed with DR; 42 (73.7%) had mild nonproliferative DR (NPDR), 7 (12.3%) had moderate NPDR, none had severe NPDR, and 8 (14.0%) had PDR. Thirty-one patients (54.4%) with retinopathy diagnoses were referred for an in-person follow-up at the clinic while the rest continued monitoring via the program. Of this subset, 22 (71.0%) completed the follow-up visit. Part 2: The survey respondents comprised 28 physicians (77.8%), 6 licensed nurse practitioners (16.7%), and 2 medical assistants (5.6%). Twenty-two providers (71.0%) preferred initiating referrals for in-person annual examinations over teleophthalmology screening referrals. The most common barriers described were related to workflow interruption, time constraints, and staff shortages. Conclusions: The teleophthalmology DR screening program allowed identification of early or absent DR at clinics in an urban setting (New York City). The findings suggest areas for targeted improvement in the screening program to better complement internal referral practices’ workflows.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"45 5","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139174721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Disease Awareness Among Patients With Age-Related Macular Degeneration: Patterns and Predictors 老年性黄斑变性患者对疾病的认识：模式与预测因素

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-14 DOI: 10.1177/24741264231210078

Brian T. Cheng, Anne B. Kim, Alice T. Lyon, R. Mirza

{"title":"Disease Awareness Among Patients With Age-Related Macular Degeneration: Patterns and Predictors","authors":"Brian T. Cheng, Anne B. Kim, Alice T. Lyon, R. Mirza","doi":"10.1177/24741264231210078","DOIUrl":"https://doi.org/10.1177/24741264231210078","url":null,"abstract":"Purpose: To examine the prevalence and predictors of patient awareness of their disease in adults with age-related macular degeneration (AMD). Methods: This study analyzed 5553 adults 40 years or older in the 2005–2008 National Health and Nutrition Examination Survey who underwent retinal imaging. AMD was determined based on retinal images. Patient awareness of their AMD was assessed by a self-reported AMD diagnosis. Multivariable logistic regression models were constructed to examine the association of patient awareness of their AMD with sociodemographic characteristics and specific AMD lesion types on retinal imaging. Results: AMD was identified in 425 of the adults surveyed (6.5%) (95% confidence interval [CI], 5.5%-7.5%), including 87.7% (95% CI, 82.9%-92.5%) with early AMD and 12.3% (95% CI, 7.5%-17.1%) with late AMD. Among adults with either type of AMD on retinal imaging, 17.5% (95% CI, 13.1%-22.0%) were aware of their disease, which included 11.6% (95% CI, 8.4%-14.9%) with early AMD and 59.2% (95% CI, 43.1%-75.3%) with late AMD ( P < .0001). In the same group, those aged 60 years or older (odds ratio [OR], 33.46; 95% CI, 7.67-146.03) and with a best-corrected visual acuity of 20/40 or worse (OR, 4.63; 95% CI, 2.95-7.26) had higher awareness of their AMD diagnosis, whereas Hispanic (OR, 0.28; 95% CI, 0.09-0.88) vs White adults and those who did not speak English at home (OR, 0.05; 95% CI, 0.01-0.41) had lower awareness of their diagnosis. Conclusions: Fewer than 1 in 5 adults with AMD were aware of their personal diagnosis, including fewer than 3 in 5 adults with late AMD. Older adults and those with worse vision were more likely to know they have AMD, whereas Hispanic adults and those who did not speak English at home were less likely. Efforts to increase patients’ awareness of their AMD may improve rates of follow-up and prevent vision loss.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":"17 6","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138971538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma 一例侵袭性复发性黑色素瘤的基因表达谱等级变化

IF 0.6

Journal of VitreoRetinal Diseases Pub Date : 2023-12-01 DOI: 10.1177/24741264231215536

Jennifer Aye, Aaron Gold, Belinda Rodriguez, Timothy Murray

引用次数: 0